ATC代碼 (C02)

ATC代碼C02(抗高血壓藥)是解剖學治療學及化學分類系統的一個藥物分組,這是由世界衛生組織藥物統計方法整合中心(The WHO Collaborating Centre for Drug Statistics Methodology)所制定的藥品及其它醫用產品的官方分類系統。分組C02是C心血管系統的一部分。[1]

ATC代碼
C 心血管系統
C01 心臟治療(Cardiac therapy)
C02 抗高血壓藥(Antihypertensives)
C03 利尿藥(Diuretics)
C04 外周血管擴張藥(Peripheral vasodilators)
C05 血管保護劑(Vasoprotectives)
C07 β阻滯劑(Beta blocking agents)
C08 鈣通道阻滯劑(Calcium channel blockers)
C09 作用在腎素-血管緊張素系統上的藥劑(Agents acting on the renin-angiotensin system)
C10 血脂調節劑(Lipid modifying agents)

A·B·C·D·G·H·QI·J·L·M·N·P·R·S·V

獸用代碼(ATCvet碼)可以在人用ATC代碼前加Q字母:QC02[2]

國家ATC分類可能包括列表中沒有的其它分類,列表為世界衛生組織(WHO)版本。

C02A 起中心作用的抗腎上腺素能藥(Antiadrenergic agents, centrally acting)

C02AA 蛇根木生物鹼類(Rauwolfia alkaloids)

C02AA01 瑞西那明(Rescinnamine)
C02AA02 利舍平(Reserpine)
C02AA03 蛇根木生物鹼複方(Combinations of rauwolfia alkaloids)
C02AA04 蛇根木生物鹼,全(Rauwolfia alkaloids, whole root)
C02AA05 地舍平(Deserpidine)
C02AA06 美索舍平(Methoserpidine)
C02AA07 比他舍平(Bietaserpine)
C02AA52 利舍平複方(Reserpine, combinations)
C02AA53 蛇根木生物鹼複方(Combinations of rauwolfia alkoloids, combinations)
C02AA57 比他舍平複方(Bietaserpine, combinations)

C02AB 甲基多巴類(Methyldopa)

C02AB01 甲基左旋多巴(Methyldopa (levorotatory))
C02AB02 甲基多巴(消旋)(Methyldopa (racemic))

C02AC 咪唑啉受體激動藥(Imidazoline receptor agonists)

C02AC01 可樂定(Clonidine)
C02AC02 胍法辛(Guanfacine)
C02AC04 托洛尼定(Tolonidine)
C02AC05 莫索尼定(Moxonidine)
C02AC06 利美尼定(Rilmenidine)

C02B 起神經節阻滯作用的抗腎上腺素能藥(Antiadrenergic agents, ganglion-blocking)

C02BA 鋶衍生物(Sulfonium derivatives)

C02BA01 樟磺咪芬(Trimetaphan)

C02BB 仲胺和叔胺類(Secondary and tertiary amines)

C02BB01 美卡拉明(Mecamylamine)

C02BC 雙季銨鹽化合物(Bisquaternary ammonium compounds)

C02C 外周作用的抗腎上腺素能藥(Antiadrenergic agents, peripherally acting)

C02CA α-腎上腺素受體拮抗藥(Alpha-adrenoreceptor antagonists)

C02CA01 哌唑嗪(Prazosin)
C02CA02 吲哚拉明(Indoramin)
C02CA03 曲馬唑嗪(Trimazosin)
C02CA04 多沙唑嗪(Doxazosin)
C02CA06 烏拉地爾(Urapidil)

C02CC 衍生物(Guanidine derivatives)

C02CC01 倍他尼定(Betanidine)
C02CC02 胍乙啶(Guanethidine)
C02CC03 胍生(Guanoxan)
C02CC04 異喹胍(Debrisoquine)
C02CC05 胍氯酚(Guanoclor)
C02CC06 胍那佐定(Guanazodine)
C02CC07 胍諾沙苄(Guanoxabenz)

C02D 作用於小動脈平滑肌的藥物(Arteriolar smooth muscle, agents acting on)

C02DA 噻嗪衍生物(Thiazide derivatives)

C02DA01 二氮嗪(Diazoxide)

C02DB 肼酞嗪衍生物(Hydrazinophthalazine derivatives)

C02DB01 雙肼屈嗪(Dihydralazine)
C02DB02 肼屈嗪(Hydralazine)
C02DB03 恩屈嗪(Endralazine)
C02DB04 卡屈嗪(Cadralazine)

C02DC 嘧啶衍生物(Pyrimidine derivatives)

C02DC01 米諾地爾(Minoxidil)

C02DD 亞硝基鐵氰化物衍生物(Nitroferricyanide derivatives)

C02DD01 硝普鹽(Nitroprusside)

C02DG 胍衍生物(Guanidine derivatives)

C02DG01 吡那地爾(Pinacidil)

C02K 其他抗高血壓藥(Other antihypertensives)

C02KA 非蛇根木類生物鹼(Alkaloids, excluding rauwolfia)

C02KA01 藜蘆(Veratrum)

C02KB 酪氨酸羥化酶抑制藥(Tyrosine hydroxylase inhibitors)

C02KB01 甲酪氨酸(Metirosine)

C02KC 單胺氧化酶抑制藥(MAO inhibitors)

C02KC01 帕吉林(Pargyline)

C02KD 5-羥色胺拮抗藥(Serotonin antagonists)

C02KD01 酮色林(Ketanserin)

C02KX 其它抗高血壓藥(Other antihypertensives)

C02KX01 波生坦(Bosentan)
C02KX02 安利生坦(Ambrisentan)
C02KX03 西他生坦(Sitaxentan)

C02L 抗高血壓藥和利尿藥的複方(Antihypertensives and diuretics in combination)

C02LA 蛇根木生物鹼和利尿藥的複方(Rauwolfia alkaloids and diuretics in combination)

C02LA01 利舍平和利尿藥(Reserpine and diuretics)
C02LA02 瑞西那明和利尿藥(Rescinnamine and diuretics)
C02LA03 地舍平和利尿藥(Deserpidine and diuretics)
C02LA04 美索舍平和利尿藥(Methoserpidine and diuretics)
C02LA07 比他舍平和利尿藥(Bietaserpine and diuretics)
C02LA08 蛇根木生物鹼,全根和利尿藥(Rauwolfia alkaloids, whole root and diuretics)
C02LA09 昔洛舍平和利尿藥(Syrosingopine and diuretics)
C02LA50 蛇根木生物鹼和利尿藥的複方,含其它複方(Combinations of rauwolfia alkaloids and diuretics including other combinations)
C02LA51 利舍平和利尿藥以及其它藥物的複方(Reserpine and diuretics, combinations with other drugs)
C02LA52 瑞西那明和利尿藥以及其它藥物的複方(Rescinnamine and diuretics, combinations with other drugs)
C02LA71 利舍平和利尿藥以及與安定藥的複方(Reserpine and diuretics, combinations with psycholeptics)

C02LB 甲基多巴和利尿藥複方(Methyldopa and diuretics in combination)

C02LB01 甲基左旋多巴和利尿藥(Methyldopa (levorotatory) and diuretics)

C02LC 咪唑啉受體激動藥與利尿藥複方(Imidazoline receptor agonists in combination with diuretics)

C02LC01 可樂定和利尿藥(Clonidine and diuretics)
C02LC05 莫索尼定和利尿藥(Moxonidine and diuretics)
C02LC51 可樂定和利尿藥以及其它藥物的複方(Clonidine and diuretics, combinations with other drugs)

C02LE α-腎上腺素受體拮抗藥和利尿藥(Alpha-adrenoreceptor antagonists and diuretics)

C02LE01 哌唑嗪和利尿藥(Prazosin and diuretics)

C02LF 胍衍生物和利尿藥(Guanidine derivatives and diuretics)

C02LF01 胍乙啶和利尿藥(Guanethidine and diuretics)

C02LG 肼酞嗪衍生物和利尿藥(Hydrazinophthalazine derivatives and diuretics)

C02LG01 雙肼屈嗪和利尿藥(Dihydralazine and diuretics)
C02LG02 肼屈嗪和利尿藥(Hydralazine and diuretics)
C02LG03 吡考屈嗪和利尿藥(Picodralazine and diuretics)
C02LG51 雙肼屈嗪和利尿藥以及其它藥物的複方(Dihydralazine and diuretics, combinations with other drugs)
C02LG73 吡考屈嗪和利尿藥以及安定藥的複方(Picodralazine and diuretics, combinations with psycholeptics)

C02LK 非蛇根木類生物鹼和利尿藥的複方(Alkaloids, excluding rauwolfia, in combination with diuretics)

C02LK01 藜蘆和利尿藥(Veratrum and diuretics)

C02LL 單胺氧化酶抑制藥和利尿藥(MAO inhibitors and diuretics)

C02LL01 帕吉林和利尿藥(Pargyline and diuretics)

C02LN 5-羥色胺拮抗藥和利尿藥(Serotonin antagonists and diuretics)

C02LX 其它抗高血壓藥和利尿藥(Other antihypertensives and diuretics)

C02LX01 吡那地爾和利尿藥(Pinacidil and diuretics)

C02N 抗高血壓藥的複方(Combinations of antihypertensives in ATC-group C02)

空組

參考文獻

  1. ^ ATC Index. WHO Collaborating Centre for Drug Statistics Methodology. 
  2. ^ ATCvet Index. WHO Collaborating Centre for Drug Statistics Methodology.